AlfaMed S.r.l. is an Italian company based in Porto San Giorgio (FM), specializing in the development and production of medical devices and equipment for pain therapy, spinal surgery, neurosurgery and interventional radiology.

Continental Investment Partners (CIP) is a Swiss private equity fund focused on healthcare and Medtech investments.

Cross Border advised the shareholders of AlfaMed on the sale of a majority stake to Continental Investment Partners (CIP).

The transaction will support AlfaMed’s accelerated international expansion strategy, strengthening its leadership as a key partner for hospitals and clinics in Italy and abroad.

In 2025, AlfaMed recorded a 25% revenue increase compared to the previous year, reaching €10 million in revenues and an EBITDA margin of 33%.

Cross Border managed the process under an exclusive sell-side mandate, identifying the ideal partner, structuring the transaction, and coordinating legal and tax advisors from origination through closing.